• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Introduction to 7-Bromoquinoline-3-carbaldehyde (CAS No. 745830-24-4)

7-Bromoquinoline-3-carbaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 745830-24-4, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the quinoline family, which is well-documented for its broad spectrum of biological activities and utility in drug development. The presence of both a bromine substituent at the 7-position and an aldehyde group at the 3-position imparts unique chemical properties, making it a valuable intermediate in synthetic chemistry and a promising candidate for further exploration in medicinal applications.

The structural features of 7-Bromoquinoline-3-carbaldehyde contribute to its reactivity and potential biological functions. The bromine atom introduces electrophilic characteristics, facilitating nucleophilic substitution reactions, while the aldehyde group serves as a versatile functional handle for further derivatization. These attributes have positioned this compound as a key building block in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

In recent years, there has been a surge in research focused on quinoline derivatives due to their demonstrated efficacy against various diseases, including infectious disorders and cancer. The bromo-substituted quinolines have been particularly studied for their ability to interact with biological targets such as enzymes and receptors, modulating pathways that are relevant to disease progression. For instance, modifications of the quinoline scaffold have led to the discovery of compounds with antimalarial, antibacterial, and anticancer properties.

One of the most compelling aspects of 7-Bromoquinoline-3-carbaldehyde is its role as a precursor in the synthesis of biologically active molecules. The aldehyde functionality allows for condensation reactions with various nucleophiles, such as amines and hydrazines, leading to imines or hydrazones. These intermediates can then be further functionalized to produce more complex structures. For example, recent studies have demonstrated the use of 7-Bromoquinoline-3-carbaldehyde in the preparation of quinoline-based inhibitors targeting specific enzymes involved in cancer metabolism. Such inhibitors have shown promise in preclinical studies, highlighting the potential of this compound as a lead structure.

The bromine atom at the 7-position also provides an opportunity for further chemical manipulation through cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions enable the introduction of aryl or heteroaryl groups at various positions on the quinoline ring, expanding the structural diversity of derived compounds. In particular, research has focused on generating quinoline derivatives that exhibit enhanced binding affinity to therapeutic targets, thereby improving drug efficacy.

Moreover, 7-Bromoquinoline-3-carbaldehyde has been explored in the context of developing novel antimicrobial agents. Quinoline derivatives are known for their activity against resistant bacterial strains, making them attractive candidates for addressing emerging infectious diseases. The bromine substituent enhances lipophilicity and metabolic stability, which are critical factors for drug bioavailability and efficacy. Recent computational studies have identified 7-Bromoquinoline-3-carbaldehyde as a scaffold that can be modified to target bacterial enzymes involved in DNA replication and transcription, offering a new avenue for combating antibiotic-resistant pathogens.

The compound’s versatility also extends to its application in material science and organic synthesis. Its ability to undergo multiple functionalization reactions makes it a valuable asset in designing novel materials with specific electronic or optical properties. Additionally, its role as a building block in multi-step syntheses underscores its importance in academic and industrial research settings.

From a synthetic chemistry perspective, 7-Bromoquinoline-3-carbaldehyde exemplifies how strategic functionalization can yield compounds with diverse applications. The balance between electrophilic and nucleophilic sites allows for controlled modifications, enabling chemists to tailor molecular structures to meet specific biological or material science objectives. This adaptability has made it a staple in synthetic laboratories focused on developing innovative chemical entities.

In conclusion,7-Bromoquinoline-3-carbaldehyde (CAS No. 745830-24-4) represents a fascinating compound with substantial potential across multiple domains of chemistry and biology. Its unique structural features make it an indispensable tool for researchers aiming to develop new drugs, materials, or synthetic methodologies. As ongoing studies continue to uncover new applications and functionalities associated with this compound, its significance is expected to grow further within the scientific community.

• 877-03-2(5-Bromo-1H-indole-3-carbaldehyde)
• 898404-22-3(7-Bromoquinoline-4-carbaldehyde)
• 898391-75-8(6-Bromoquinoline-4-carbaldehyde)
• 892874-34-9(7-Bromoquinoline-3-carboxylic acid)
• 1196155-68-6(6-Bromoquinoline-3-carbaldehyde)
• 885267-41-4(5-Bromoquinoline-8-carbaldehyde)
• 1416438-47-5(5-bromoquinoline-3-carboxylic acid)
• 17826-04-9(6-bromo-1H-indole-3-carbaldehyde)
• 98600-34-1(4-bromo-3-formylindole)
• 16076-86-1(5-Bromo-7-Methylindole-3-Carboxaldehyde)